Showing 1 - 7 results of 7 for search 'S. Niyongere', query time: 5.49s Refine Results
  1. 1
    Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

    Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia by Sandrine Niyongere, Gabriela Sanchez-Petitto, Jack Masur, Maria R. Baer, Vu H. Duong, Ashkan Emadi

    Published 2020-06-01
    Get full text
    Article
  2. 2
    Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force

    Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force by Jenna Niyongere, Timothy E. Welty, Michelle W. Bell, Damian Consalvo, Charles Hammond, Howan Leung, Philip N. Patsalos, Melody Ryan, Thanarat Suansanae, Dong Zhou, Hazel Zuellig

    Published 2022-06-01
    Get full text
    Article
  3. 3
    Therapy-related B-lymphoblastic leukemia after multiple myeloma

    Therapy-related B-lymphoblastic leukemia after multiple myeloma by Michael E. Kallen, Rima Koka, Zeba N. Singh, Yi Ning, Mehmet H. Kocoglu, Ashraf Z. Badros, Sandrine Niyongere, Vu H. Duong, Ashkan Emadi, Maria R. Baer

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

    Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study by Elizabeth M. Corley, Moaath K. Mustafa Ali, Moaath K. Mustafa Ali, Hanan Alharthy, Kathryn A. F. Kline, Kathryn A. F. Kline, Danielle Sewell, Jennie Y. Law, Jennie Y. Law, Seung Tae Lee, Seung Tae Lee, Sandrine Niyongere, Sandrine Niyongere, Vu H. Duong, Vu H. Duong, Maria R. Baer, Maria R. Baer, Ashkan Emadi, Ashkan Emadi, Ashkan Emadi, Ashkan Emadi

    Published 2022-03-01
    Get full text
    Article
  5. 5
    Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

    Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study by Moaath K. Mustafa Ali, Moaath K. Mustafa Ali, Elizabeth M. Corley, Hanan Alharthy, Kathryn A. F. Kline, Kathryn A. F. Kline, Jennie Y. Law, Jennie Y. Law, Seung Tae Lee, Seung Tae Lee, Sandrine Niyongere, Sandrine Niyongere, Vu H. Duong, Vu H. Duong, Ashkan Emadi, Ashkan Emadi, Ashkan Emadi, Ashkan Emadi, Maria R. Baer, Maria R. Baer

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

    Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study by Elizabeth M. Corley, Moaath K. Mustafa Ali, Hanan Alharthy, Kathryn A. F. Kline, Danielle Sewell, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Ashkan Emadi

    Published 2022-06-01
    Get full text
    Article
  7. 7
    P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS

    P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FI... by Y. Liu, O. M. Bah, D. Bollino, K. Caprinolo, J. Zarrabi, S. Philip, R. G. Lapidus, E. T. Strovel, Z. N. Singh, M. E. Kallen, Y. Ning, R. Koka, S. Niyongere, V. H. Duong, M. R. Baer, M. Graveno, A. Emadi

    Published 2022-06-01
    Get full text
    Article

Search Tools: